Rule to Lower Drug Prices Would Do the Opposite

In the Rube Goldberg machine that is America's $3.5 trillion health-care system, it can be hard to tell when a “solution” is really a new problem in disguise. It also can be difficult to tell which of the squabbling institutional players is the arch villain, merely the villain, or the somewhat valiant knight whose armor isn't too tarnished.